Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer

Keyphrases

• Treatment Duration 100%
• Endometrial Cancer 100%
• Advanced Stage 100%
• Concomitant Chemotherapy 100%
• Chemotherapy 66%
• Stage III-IV 66%
• Inclusion Criteria 33%
• Blood Transfusion 33%
• Leukocytes 33%
• Overall Survival 33%
• Median Overall Survival 33%
• Median Progression-free Survival 33%
• Dose Reduction 33%
• Growth Factors 33%
• Radiation Therapy 33%
• Kaplan-Meier Method 33%
• Adjuvant Therapy 33%
• Concurrent Chemotherapy 33%
• Gastrointestinal 33%
• Common Terminology Criteria for Adverse Events (CTCAE) 33%
• Treatment Toxicity 33%
• Hematologic 33%
• Treatment Modalities 33%
• Descriptive Statistics 33%
• Stage III Disease 33%
• Carcinosarcoma 33%
• Neuropathy 33%
• Concurrent Radiation 33%
• Serous 33%
• Endometrioid 33%
• Treatment Survival 33%
• Clear Cell Histology 33%
• Short-term Treatment 33%
• EORTC 33%
• Mixed Histology 33%
• Stage IVB 33%

Medicine and Dentistry

• Uterine Cancer 100%
• Chemotherapy 100%
• Treatment Duration 50%
• Overall Survival 33%
• Blood Transfusion 16%
• Progression Free Survival 16%
• Disease 16%
• Leukocyte 16%
• Radiation Therapy 16%
• Growth Factor 16%
• Kaplan Meier Method 16%
• Neuropathy 16%
• Carcinosarcoma 16%
• Adjuvant Therapy 16%
• Clear Cell 16%
• Survival Estimate 16%
• Drug Dose Reduction 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 100%
• Endometrium Cancer 100%
• Overall Survival 33%
• Disease 16%
• Progression Free Survival 16%
• Growth Factor 16%
• Carcinosarcoma 16%
• Neuropathy 16%